Victoria Benedi-Marco

Zaragoza, AR, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

The Spanish Atherosclerosis Society Dyslipidaemia Registry: Evolution, real-world evidence, and its role in precision medicine. Current status in 2026.

The Spanish Atherosclerosis Society Dyslipidaemia Registry: Evolution, real-world evidence, and its role in precision medicine. Current status in 2026.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis

Published: June 17, 2026

Sequencing and functional characterization of SCARB1 variants in subjects with extreme HDL cholesterol levels.

Sequencing and functional characterization of SCARB1 variants in subjects with extreme HDL cholesterol levels.

Journal: Journal of clinical lipidology

Published: July 09, 2025

APOE p.(Leu167del) variant in hypercholesterolemia: Prevalence & phenotypic expression.

APOE p.(Leu167del) variant in hypercholesterolemia: Prevalence & phenotypic expression.

Journal: Journal of clinical lipidology

Published: May 20, 2025

Classification, prevalence and cardiovascular risk of different types of hypercholesterolemia.

Classification, prevalence and cardiovascular risk of different types of hypercholesterolemia.

Journal: Revista espanola de cardiologia (English ed.)

Published: May 12, 2025

Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach.

Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach.

Journal: European heart journal. Digital health

Published: February 12, 2025

Association of HDL cholesterol with all-cause and cardiovascular mortality in primary hypercholesterolemia.

Association of HDL cholesterol with all-cause and cardiovascular mortality in primary hypercholesterolemia.

Journal: Atherosclerosis

Published: August 02, 2024

PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention.

PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention.

Journal: Lipids in health and disease

Published: June 24, 2024

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.

Journal: International journal of molecular sciences

Published: March 25, 2024

Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.

Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis

Published: October 07, 2023

Low-Quality Carbohydrate Intake Is Associated With a Higher Prevalence of Metabolic Syndrome: The AWHS Study.

Low-Quality Carbohydrate Intake Is Associated With a Higher Prevalence of Metabolic Syndrome: The AWHS Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 25, 2023

Factors associated with the presence of tendon xanthomas in familial hypercholesterolemia.

Factors associated with the presence of tendon xanthomas in familial hypercholesterolemia.

Journal: Revista espanola de cardiologia (English ed.)

Published: September 20, 2023

Impact of conducting a genetic study on the management of familial hypercholesterolemia.

Impact of conducting a genetic study on the management of familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: May 04, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026